24 HR Glipizide 5 MG Extended Release Oral Tablet

1 INDICATIONS AND USAGE Glipizide extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Glipizide extended-release tablets are a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus Limitations of Use: Not for treatment of type 1 diabetes or diabetic ketoacidosi s 1.1 Limitations of Use Glipizide extended-release tablets are not recommended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.

Mylan Pharmaceuticals Inc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] toxicity to various agents` `[3] completed suicide` `[4] drug abuse` `[5] off label use` `[6] fatigue` `[7] death` `[8] seizure` `[9] nausea` `[10] dyspnoea`

3 years ago

ROUND WHITE M GP5

16 HOW SUPPLIED/STORAGE AND HANDLING Glipizide Extended-Release Tablets are available containing 2.5 mg, 5 mg or 10 mg of glipizide, USP. The 2.5 mg tablets are light blue, film-coated, round, unscored tablets with M over GP2 imprinted in black ink on one side of the tablet and blank on the other side. They are available as follows: NDC 0378-0340-93 bottles of 30 tablets The 5 mg tablets are white, film-coated, round, unscored tablets with M over GP5 imprinted in black ink on one side of the tablet and blank on the other side. They are available as follows: NDC 0378-0342-01 bottles of 100 tablets NDC 0378-0342-10 bottles of 1000 tablets The 10 mg tablets are white, film-coated, round, unscored tablets with M over GP10 imprinted in black ink on one side of the tablet and blank on the other side. They are available as follows: NDC 0378-0431-01 bottles of 100 tablets NDC 0378-0431-10 bottles of 1000 tablets Recommended Storage: Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from moisture and humidity. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. PHARMACIST: Dispense a Patient Information Leaflet with each prescription.

More pills like ROUND M GP5

Related Pills

24 HR Glipizide 10 MG Extended Release Oral Tablet

Mylan Pharmaceuticals Inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site